PMID- 22648490
OWN - NLM
STAT- MEDLINE
DCOM- 20121022
LR  - 20120531
IS  - 1098-9048 (Electronic)
IS  - 1069-3424 (Linking)
VI  - 33
IP  - 2
DP  - 2012 Apr
TI  - Interventional approaches in VTE treatment (vena cava filters, catheter-guided 
      thrombolysis, thrombosuction).
PG  - 176-85
LID - 10.1055/s-0032-1311796 [doi]
AB  - Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary 
      embolism (PE), is the third most common cardiovascular pathology after coronary 
      disease and cerebrovascular diseases and is responsible for significant morbidity 
      and mortality in the general population. Full-dose anticoagulation is the 
      standard therapy for VTE, both the acute phase and the prolonged treatment. The 
      latest guidelines of the American College of Chest Physicians recommend treatment 
      with a full-dose of unfractionated heparin (UFH), low-molecular-weight-heparin 
      (LMWH), fondaparinux, vitamin K antagonist (VKA), or systemically administered 
      thrombolytics for most of the patients with objectively confirmed VTE. 
      Catheter-guided thrombolysis and thrombosuction are interventional approaches 
      that should be used only in selected populations; interruption of the inferior 
      vena cava (IVC) with a filter can be performed to prevent life-threatening PE in 
      patients with VTE and contraindications to anticoagulant treatment, bleeding 
      complications during antithrombotic treatment, or VTE recurrences, despite 
      optimal anticoagulation. This review summarizes the currently available 
      literature regarding interventional approaches in VTE treatment (vena cava 
      filters, catheter-guided thrombolysis, thrombosuction), discusses their efficacy 
      and safety, and reviews the appropriate indications for their use in daily 
      clinical practice.
CI  - Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
FAU - Imberti, Davide
AU  - Imberti D
AD  - Department of Internal Medicine, Piacenza Hospital, Via Taverna 49, Piacenza, 
      Italy. d.imberti@ausl.pc.it
FAU - Maraldi, Cinzia
AU  - Maraldi C
FAU - Gallerani, Massimo
AU  - Gallerani M
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20120530
PL  - United States
TA  - Semin Respir Crit Care Med
JT  - Seminars in respiratory and critical care medicine
JID - 9431858
RN  - 0 (Anticoagulants)
SB  - IM
MH  - Anticoagulants/administration & dosage/therapeutic use
MH  - Catheterization/adverse effects/methods
MH  - Humans
MH  - Mechanical Thrombolysis/adverse effects/methods
MH  - *Practice Guidelines as Topic
MH  - Pulmonary Embolism/epidemiology/pathology/*therapy
MH  - Thrombolytic Therapy/adverse effects/methods
MH  - Vena Cava Filters/adverse effects
MH  - Venous Thrombosis/epidemiology/pathology/*therapy
EDAT- 2012/06/01 06:00
MHDA- 2012/10/23 06:00
CRDT- 2012/06/01 06:00
PHST- 2012/06/01 06:00 [entrez]
PHST- 2012/06/01 06:00 [pubmed]
PHST- 2012/10/23 06:00 [medline]
AID - 10.1055/s-0032-1311796 [doi]
PST - ppublish
SO  - Semin Respir Crit Care Med. 2012 Apr;33(2):176-85. doi: 10.1055/s-0032-1311796. 
      Epub 2012 May 30.